3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Waldenstrom Macroglobulinemia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Myelodysplastic-Myeloproliferative Diseases
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Prolymphocytic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Chromosome 17 deletion
1
Interventions
Dexamethasone
111
Cyclophosphamide
99
Melphalan
91
Bortezomib
69
Peripheral Blood Stem Cell Transplantation
64
Lenalidomide
58
fludarabine phosphate
56
Busulfan
54
Filgrastim
50
Tacrolimus
38
Antilymphocyte Serum
38
Thalidomide
36
Radiotherapy
36
Mycophenolic Acid
33
fludarabine
28
Cyclosporine
26
Methotrexate
25
Etoposide
22
Calcium Dobesilate
22
Whole-Body Irradiation
21
Prednisone
21
Methylprednisolone
20
sargramostim
19
pomalidomide
19
Granulocyte Colony-Stimulating Factor
18
carfilzomib
16
daratumumab
15
Cord Blood Stem Cell Transplantation
15
Carmustine
14
Rituximab
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
Atorvastatin
×
Plasma cell
×
Clear all
NCT00164086
2006-10-11
Atorvastatin in Myeloma
Bayside Health
Phase 1
Unknown